gaap:CorporateNonSegmentMember
amgn:ReportableSegmentMember
2025-01-01
2025-03-31
0000318154
us-gaap:CorporateNonSegmentMember
amgn:ReportableSegmentMember
2024-01-01
2024-03-31
0000318154
amgn:ReportableSegmentMember
2025-01-01
2025-03-31
0000318154
amgn:ReportableSegmentMember
2024-01-01
2024-03-31
0000318154
us-gaap:FairValueAdjustmentToInventoryMember
2025-01-01
2025-03-31
0000318154
us-gaap:FairValueAdjustmentToInventoryMember
2024-01-01
2024-03-31
0000318154
country:US
amgn:ProliaMember
2025-01-01
2025-03-31
0000318154
us-gaap:NonUsMember
amgn:ProliaMember
2025-01-01
2025-03-31
0000318154
amgn:ProliaMember
2025-01-01
2025-03-31
0000318154
country:US
amgn:ProliaMember
2024-01-01
2024-03-31
0000318154
us-gaap:NonUsMember
amgn:ProliaMember
2024-01-01
2024-03-31
0000318154
amgn:ProliaMember
2024-01-01
2024-03-31
0000318154
country:US
amgn:RepathaevolocumabMember
2025-01-01
2025-03-31
0000318154
us-gaap:NonUsMember
amgn:RepathaevolocumabMember
2025-01-01
2025-03-31
0000318154
amgn:RepathaevolocumabMember
2025-01-01
2025-03-31
0000318154
country:US
amgn:RepathaevolocumabMember
2024-01-01
2024-03-31
0000318154
us-gaap:NonUsMember
amgn:RepathaevolocumabMember
2024-01-01
2024-03-31
0000318154
amgn:RepathaevolocumabMember
2024-01-01
2024-03-31
0000318154
country:US
amgn:XgevaMember
2025-01-01
2025-03-31
0000318154
us-gaap:NonUsMember
amgn:XgevaMember
2025-01-01
2025-03-31
0000318154
amgn:XgevaMember
2025-01-01
2025-03-31
0000318154
country:US
amgn:XgevaMember
2024-01-01
2024-03-31
0000318154
us-gaap:NonUsMember
amgn:XgevaMember
2024-01-01
2024-03-31
0000318154
amgn:XgevaMember
2024-01-01
2024-03-31
0000318154
country:US
amgn:EnbrelMember
2025-01-01
2025-03-31
0000318154
us-gaap:NonUsMember
amgn:EnbrelMember
2025-01-01
2025-03-31
0000318154
amgn:EnbrelMember
2025-01-01
2025-03-31
0000318154
country:US
amgn:EnbrelMember
2024-01-01
2024-03-31
0000318154
us-gaap:NonUsMember
amgn:EnbrelMember
2024-01-01
2024-03-31
0000318154
amgn:EnbrelMember
2024-01-01
2024-03-31
0000318154
country:US
amgn:EVENITYMember
2025-01-01
2025-03-31
0000318154
us-gaap:NonUsMember
amgn:EVENITYMember
2025-01-01
2025-03-31
0000318154
amgn:EVENITYMember
2025-01-01
2025-03-31
0000318154
country:US
amgn:EVENITYMember
2024-01-01
2024-03-31
0000318154
us-gaap:NonUsMember
amgn:EVENITYMember
2024-01-01
2024-03-31
0000318154
amgn:EVENITYMember
2024-01-01
2024-03-31
0000318154
country:US
amgn:OtezlaMember
2025-01-01
2025-03-31
0000318154
us-gaap:NonUsMember
amgn:OtezlaMember
2025-01-01
2025-03-31
0000318154
amgn:OtezlaMember
2025-01-01
2025-03-31
0000318154
country:US
amgn:OtezlaMember
2024-01-01
2024-03-31
0000318154
us-gaap:NonUsMember
amgn:OtezlaMember
2024-01-01
2024-03-31
0000318154
amgn:OtezlaMember
2024-01-01
2024-03-31
0000318154
country:US
amgn:TEPEZZAMember
2025-01-01
2025-03-31
0000318154
us-gaap:NonUsMember
amgn:TEPEZZAMember
2025-01-01
2025-03-31
0000318154
amgn:TEPEZZAMember
2025-01-01
2025-03-31
0000318154
country:US
amgn:TEPEZZAMember
2024-01-01
2024-03-31
0000318154
us-